Accelrys Looks to India to Accelerate R&D Amid Informatics Spending Slump | GenomeWeb

Taking a page from the big IT playbook, Accelrys is opening a new development center in Bangalore, India, “to capitalize on the high-quality, low-cost software development capabilities” in the region, according to Joseph Mollica, CEO of Accelrys’ parent company Pharmacopeia.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.